Answer
Yes, Fibrovein (sodium tetradecyl sulfate) is contraindicated when converted to foam in people with a known symptomatic patent foramen ovale (PFO).
Sources for this answer
- Fibrovein 3%, 1%, 0.5%, 0.2%STD Pharmaceutical Products Ltd · emc · SmPC §4.3 Contraindications · Version 3Document updated
Sources checked